Ginsenoside compound K was reported to enhance autophagy in primary astrocytes by target of mTOR (mammalian target of rapamycin), which may promote β-amyloid peptide clearance and slow the pathological progression of AD (Guo et al., 2014). This evidence concerns the gene MTOR and Alzheimer disease.